Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more.
Lonza-owned Synaffix boosted its licensing deal with Innovent Biologics on Wednesday to make at least one new ADC candidate, building upon the companies’ original deal in June 2021. Innovent will use Synaffix’s ADC manufacturing technology to develop new ADC candidates. Synaffix will receive an upfront payment as well as further milestone payments and royalties for each commercialized ADC.
Recipharm partnered with the CRO Oz-UK to manufacture more eco-friendly pressurized metered dose inhalers (pMDIs) on Tuesday. The new pMDIs will use valves and actuators from another one of Recipharm’s inhalers and will incorporate sustainable propellants, called Zephex HFA-152a, made by the fluoroproduct manufacturer Koura.
Colorado-based VitriVax received a $5 million two-year grant from the Bill & Melinda Gates Foundation…
Click here to view original post
